Key statistics
As of last trade Geron Corp (GON:DUS) traded at 3.84, -21.35% below its 52-week high of 4.89, set on Jun 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.81 |
---|---|
High | 3.84 |
Low | 3.80 |
Bid | 3.90 |
Offer | 3.94 |
Previous close | 3.82 |
Average volume | 466.67 |
---|---|
Shares outstanding | 604.50m |
Free float | 603.98m |
P/E (TTM) | -- |
Market cap | 2.43bn USD |
EPS (TTM) | -0.3221 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 15:30 GMT.
More ▼
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
- Geron to Participate in the Stifel 2024 Healthcare Conference
- Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
- Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies
- Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024
- Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer
More ▼